From October 2023, local price negotiations of commercial research for late phase studies will stop. This will be the case for all NHS organisations as the National Contract Value Review (NCVR) process stage 2 commences. It is exactly one year since stage 1 started. This marks another milestone in the UK’s progress towards achieving globally competitive study set-up times.

Please see NCVR Special Feature Newsletter